4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-23-071929
Director acquired 4,320 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
AZAB MOHAMMAD · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-19 | Exercise or conversion : show line 1 in the form | +823 | $9.85 | $8,107 | 70,728 | D |
| 2023-12-19 | Exercise or conversion : show line 2 in the form | +3,497 | $9.85 | $34,445 | 74,225 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-19 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −823 | 0 | D |
| 2023-12-19 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −3,497 | 0 | D |
Loading xslF345X05/ownership.xml…